Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) — SHAREHOLDER ALERT

Author

19 July, 2017

Zacks Investment Research lowered shares of AngioDynamics from a "buy" rating to a "hold" rating in a research note on Monday, April 10th. Craig Hallum set a $20.00 price target on shares of AngioDynamics and gave the company a "buy" rating in a research note on Saturday, April 1st.

According to the the latest analyst ratings which have been released, 0 brokers have issued a rating of "buy", 1 brokers "outperform", 4 brokers "hold", 0 brokers "underperform" and 0 brokers "sell". AngioDynamics has a consensus rating of "Buy" and a consensus target price of $18.67.

Canaccord Genuity analyst Jason Mills reiterated a Hold rating on Angiodynamics (NASDAQ: ANGO) today and set a price target of $17.

In the market the company is trading down from yesterday's close of $16.22. AngioDynamics, Inc. (NASDAQ:ANGO) shares have been recently spotted -11.28% away from the 52-week high, and 8.99% away from the 52-week low mark. After a recent look, shares have been seen -1.63% from the 200-day moving average, and 1.97% from the 50-day moving average.

In the last earnings report the EPS was $-0.70 and is projected to be $0.70 for the current year with 36,780,000 shares presently outstanding. The business had revenue of $86.90 million during the quarter, compared to analysts' expectations of $90.72 million. AngioDynamics's quarterly revenue was down 2.1% compared to the same quarter previous year. During the same quarter a year ago, the business posted $0.19 EPS. Currently, Angiodynamics has an average volume of 231.8K.

Depending on the earnings numbers reported, AngioDynamics, Inc. If you are reading this news story on another site, it was stolen and republished in violation of United States and global trademark and copyright law.

As the earnings date approaches, we can see that insider ownership is now 0.60% shares, and institutional ownership is at 86.70% for AngioDynamics, Inc. Arizona State Retirement System boosted its position in AngioDynamics by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 13,000 shares of the medical instruments supplier's stock valued at $226,000 after buying an additional 300 shares during the last quarter. The institutional investor owned 7,200 shares of the medical instruments supplier's stock after buying an additional 210 shares during the period. Finally, New York State Teachers Retirement System raised its stake in shares of AngioDynamics by 3.4% in the fourth quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier's stock worth $130,000 after buying an additional 584 shares in the last quarter. New York State Teachers Retirement System now owns 15,086 shares of the medical instruments supplier's stock valued at $255,000 after buying an additional 500 shares during the last quarter. Its activities include design, manufactures, and sale of medical, surgical and diagnostic devices.


More news